Dive into our repository of groundbreaking research papers, where we merge clinical expertise with data driven insights to revolutionize patient care and treatment strategies.
Explore the latest news about COTA, where our breakthroughs and collaborations lead the charge in transforming healthcare. Each mention underscores our role in pioneering data-driven solutions for real-world challenges.
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that brings...
New York — COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at...
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that brings...
Life science companies have many different data types at their disposal to support research and development, from established literature and...
Internships are one of the most important tools for young people preparing to transition from academia to a full-time career. ...
Summary During this episode of Real World Talk, host Kevin Keogh talks with Dr. Andrew Pecora of OMI (Outcomes Matter…
Summary During this episode of Real World Talk, host Zoe Li has a conversation with Michelle Hoiseth, the Chief Data…
Explore impactful case studies that highlight COTA’s innovative solutions in action. These stories illustrate the significant differences our data driven approach makes in patient care and healthcare improvement.
Much of today’s investigational cancer therapeutics originates in small biotechnology companies, most of which are innovative and agile by nature, but also lack the financial horsepower, resources, and infrastructure of…
Real-world data (RWD) in Oncology proves to be a vital source for clinical decisions and program decisions. COTA partnered with a Top 5 Pharma company to curate a custom multiple…
Despite advances in liquid biopsies, standard-of-care remains tissue-based genotyping, an approach that is relatively invasive, inconvenient, slow, and expensive
…
